Chongqing Medical University (CQMU), founded in 1956, is a leading public medical university in Southwest China, jointly supported by the Ministry of Education, the National Health Commission, and the Chongqing Municipal Government. CQMU has built a strong innovation-driven ecosystem that integrates education, cutting-edge research, and clinical translation, supported by an extensive network of affiliated hospitals and high-level research platforms. With strengths spanning clinical medicine, public health, biomedical sciences, and translational research, CQMU actively promotes interdisciplinary collaboration and industry partnership to accelerate discoveries from lab to bedside. Its affiliated hospitals provide a robust clinical foundation and real-world scenarios for collaborative research and international joint projects. CQMU is also highly internationalized, partnering with 67 universities and healthcare institutions across 24 countries and regions through joint labs, academic exchanges, visiting scholar programs, and joint education. As a conference host, CQMU offers an excellent gateway to connect with dynamic research teams, advanced clinical resources, and an open, collaborative environment—inviting international scholars to exchange ideas, develop partnerships, and create impactful collaborations in one of China’s most energetic innovation regions.

Nature Cell Biology publishes peer-reviewed original research of the highest quality in all areas of cell biology with an emphasis on studies that provide insights into the molecular mechanisms underlying cellular processes. The journal’s scope is broad and ranges from cytoskeletal dynamics, membrane transport, adhesion and migration, cell division, signalling pathways, development and stem cells, to molecular and cellular mechanisms underlying cancer. Nature Cell Biology provides timely and informative coverage of cell biological advances.

Nature Cancer aims to provide a unique forum through which the cancer community will learn about the latest, most significant cancer-related advances across the life, physical, applied and social sciences. Areas of interest include fundamental, preclinical research that furthers our understanding of the mechanisms underlying tumour initiation, propagation and progression; work aiming to translate this knowledge to the clinic by focusing on new approaches for the development and delivery of diagnostic and therapeutic modalities; clinical studies informing cancer diagnosis, treatment and prevention; and new ways of understanding the global societal impact of cancer. In addition to publishing original research, Nature Cancer will publish Comments, Reviews, News & Views, Features and Correspondence of high significance across the range of disciplines relating to cancer research.

Nature Biotechnology is a monthly journal covering the science and business of biotechnology. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences as well as covers the commercial, political, ethical, legal, and societal aspects of this research. The first function is fulfilled by the peer-reviewed research section, the second by the expository efforts in the front of the journal. We provide researchers with news about business; we provide the business community with news about research developments.

Nature Reviews Cancer aims to be the premier source of reviews and commentaries for the scientific communities we serve. We strive to publish articles that are authoritative, accessible and enhanced with clearly understandable figures, tables and other display items. We want to provide an unparalleled service to authors, referees and readers, and we work hard to maximize the usefulness and impact of each article. The journal publishes Research Highlights, Comments, Reviews and Perspectives relevant to cancer researchers, with our broad scope ensuring that the articles we publish reach the widest possible audience.